Skip to main content
. 2021 Apr 19;2021(4):CD013792. doi: 10.1002/14651858.CD013792.pub2

ACTRN12611000405910.

Study name Supporting Threatened Outcomes with Progesterone (STOP trial)
Methods 2‐arm placebo‐controlled randomised trial.
Participants Women aged 18 years or older presenting with threatened miscarriage and a live intrauterine pregnancy with a gestational age less than 10 weeks. Women with a pregnancy as a result of Assisted Reproductive Technologies will be excluded.
Interventions Progesterone pessary 400 mg nightly, until 12 weeks' gestation versus placebo.
Outcomes Live birth, complete miscarriage, gestation at birth, birthweight, congenital abnormality, antepartum haemorrhage.
Starting date 30‐Jan‐2012
Contact information lukemclindon@bigpond.com
Notes The trial has been completed and the findings are currently being prepared for publication.